Home » Topics » Disease categories and therapies » Respiratory

Respiratory
RSS

European Commission approves Enerzair Breezhaler for uncontrolled asthma

July 7, 2020

Dimerix advances understanding of DMX-700 in COPD

July 7, 2020

CSL Behring initiates phase II study of CSL-312 for respiratory distress in patients with COVID-19

July 7, 2020

Results from phase II RELIEF study of BLU-5937 in refractory chronic cough

July 7, 2020

Clinical study of desidustat for the management of COVID-19 approved in Mexico

July 7, 2020

AdAlta moves AD-214 into the clinic

July 7, 2020

FDA clears initiation of phase III trial of siltuximab for COVID-19-associated ARDS

July 2, 2020

FDA clears first clinical trial of M-5049 in patients with COVID-19 pneumonia

June 26, 2020

First patient dosed in phase II study of TD-0903 for the treatment of ALI caused by COVID-19

June 26, 2020

Palatin to develop PL-8177 for the treatment of COVID-19 and associated lung complications

June 25, 2020

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Jan 9, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Jan. 9, 2026.
ADCs’ breakout 2025 and their still-unfinished potential
BioWorld Science
Over the course of the year, and continuing into the latest scientific meetings, an extraordinary breadth of new antibody-drug conjugate (ADC) designs was...
Development and characterization of anti-CD19 in vivo CAR T therapy
BioWorld Science
Shenzhen Grit Biotechnology Co. Ltd. and Shanghai Vitalgen Biopharma Co. Ltd. recently presented their work to develop and evaluate a novel anti-CD19 in vivo CAR...
Preclinical results of anti-ADAMTS13 antibody in acquired von Willebrand syndrome
BioWorld Science
The acquired von Willebrand syndrome (AVWS) is a rare bleeding disorder with laboratory findings similar to those of inherited von Willebrand disease. Researchers...